BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26393293)

  • 1. Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions.
    Pule GD; Ngo Bitoungui VJ; Chetcha Chemegni B; Kengne AP; Antonarakis S; Wonkam A
    OMICS; 2015 Oct; 19(10):627-31. PubMed ID: 26393293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
    Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
    Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
    PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.
    Vathipadiekal V; Farrell JJ; Wang S; Edward HL; Shappell H; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Simkin I; Farrer LA; Jiang Z; Luo HY; Huang S; Mostoslavsky G; Murphy GJ; Patra PK; Chui DH; Alsultan A; Al-Ali AK; Sebastiani P; Steinberg MH
    Am J Hematol; 2016 Nov; 91(11):1118-1122. PubMed ID: 27501013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Nogueira BL; Belisário AR; Faria G; Mendes F; Viana MB; Luizon MR
    J Hum Genet; 2022 Dec; 67(12):701-709. PubMed ID: 36167770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
    Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
    Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.
    Ngo D; Bae H; Steinberg MH; Sebastiani P; Solovieff N; Baldwin CT; Melista E; Safaya S; Farrer LA; Al-Suliman AM; Albuali WH; Al Bagshi MH; Naserullah Z; Akinsheye I; Gallagher P; Luo HY; Chui DH; Farrell JJ; Al-Ali AK; Alsultan A
    Blood Cells Mol Dis; 2013 Jun; 51(1):22-6. PubMed ID: 23465615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
    Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
    Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon.
    Pule GD; Bitoungui VJN; Chemegni BC; Kengne AP; Wonkam A
    BMC Res Notes; 2017 May; 10(1):183. PubMed ID: 28499394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
    Leonardo FC; Brugnerotto AF; Domingos IF; Fertrin KY; de Albuquerque DM; Bezerra MA; Araújo AS; Saad ST; Costa FF; Menzel S; Conran N; Thein SL
    Br J Haematol; 2016 May; 173(3):456-60. PubMed ID: 26888013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants associated with fetal hemoglobin levels show the diverse ethnic origin in Colombian patients with sickle cell anemia.
    Fong C; Menzel S; Lizarralde MA; Barreto G
    Biomedica; 2015; 35(3):437-43. PubMed ID: 26849705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism at BCL11A compared to HBS1L-MYB loci explains less of the variance in HbF in patients with sickle cell disease in Cameroon.
    Bitoungui VJ; Ngogang J; Wonkam A
    Blood Cells Mol Dis; 2015 Mar; 54(3):268-9. PubMed ID: 25488618
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic variant in the BCL11A (rs1427407), but not HBS1-MYB (rs6934903) loci associate with fetal hemoglobin levels in Indian sickle cell disease patients.
    Bhanushali AA; Patra PK; Nair D; Verma H; Das BR
    Blood Cells Mol Dis; 2015 Jan; 54(1):4-8. PubMed ID: 25457385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
    Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
    Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.
    Bhatnagar P; Purvis S; Barron-Casella E; DeBaun MR; Casella JF; Arking DE; Keefer JR
    J Hum Genet; 2011 Apr; 56(4):316-23. PubMed ID: 21326311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.